14-3-3 σ is a new target up-regulated by transforming growth factor-β1 through a Smad3-dependent mechanism

Biochemical and Biophysical Research Communications

Volumn 432, Issue 1, 2013, Pages 193-197

  Hong, Hye Young ^a   Jeon, Woo Kwang ^a   Kim, Seong Jin ^b   Kim, Byung Chul ^a  

^a Kangwon National University   (South Korea)

^b CHA University   (South Korea)

Author keywords

14 3 3 ; Smad3; TGF 1

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SMAD3 PROTEIN; STRATIFIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION;

14-3-3 PROTEINS; ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; MICE; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84875367777     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.12.123     Document Type: Article

References (23)

1. Dong M., Blobe G.C. Role of transforming growth factor-beta in hematologic malignancies. Blood 2006, 107:4589-4596.
2. Kim B.C., Mamura M., Choi K.S., Carabretta B., Kim S.J. Transforming growth factor beta 1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells. Mol. Cell. Biol. 2002, 22:1369-1378.
3. Derynk R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature 2003, 425:577-584.
4. Massague J., Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 2000, 19:1745-1754.
5. Hayashi H., Abdollah S., Qiu Y., Cai J., Xu Y.Y., Grinnell B.W., et al. The MAD-related protein Smad7 associates with the TGF-beta receptor and functions as an antagonist of TGF-beta signaling. Cell 1997, 89:1165-1173.
6. Horiguchi K., Shirakihara T., Nakano A., Imamura T., Miyazono K., Saitoh M. Role of Ras signaling in the induction of snail by transforming growth factor-beta. J. Biol. Chem. 2009, 284:245-253.
7. Blanchette F., Rivard N., Rudd P., Grodin F., Attisano L., Dubois C.M. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transform growth factor β1-induced furin gene transactivation. J. Biol. Chem. 2001, 276:33986-33994.
8. Kamaraju A.K., Roberts A.B. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J. Biol. Chem. 2005, 280:1024-1036.
9. Morrison D.K. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 2009, 19:1-23.
10. Takahashi Y. The 14-3-3 proteins: gene, gene expression, and function. Neurochem. Res. 2003, 28:1265-1273.
11. Chan T.A., Hermeking H., Lengauer C., Kinzler K., Vogelstein B. 14-3-3 Sigma is required to prevent mitotic catastrophe after DNA damage. Science 1999, 401:616-620.
12. Subramanian R.R., Maters S.C., Zhang H., Fu H. Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. Exp. Cell Res. 2001, 271:142-151.
13. Kakinuma N., Roy B.C., Zhu Y., Wang Y., Kiyama R. Kank regulates RhoA-dependent actin stress fibers and cell migration via 14-3-3 in PI3K-Akt signaling. J. Cell Biol. 2008, 181:537-549.
14. Moreira J.M., Ohlsson G., Rank F.E., Cells J.E. Down-regulation of the tumor suppressor protein 14-3-3 sigma is a sporadic event in cancer of the breast. Mol. Cell. Proteomics 2005, 4:555-569.
15. Maxwell S.A., Li Z., Jaya D., Ballard S., Ferrell J., Fu H. 14-3-3 zeta mediates resistance of diffuse large B cell lymphoma to an anhracycline-based chemotherapeutic regimen. J. Biol. Chem. 2009, 284:22379-22389.
16. Hong H.Y., Jeon W.K., Bae E.J., Kim S.T., Lee H.J., Kim S.J., Kim B.C. 14-3-3 sigma and 14-3-3 zeta plays an opposite role in cell growth inhibition mediated by transforming growth factor-beta1. Mol. Cells 2010, 29:305-309.
17. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:575156-575159.
18. Fujii M., Takeda K., Imamura T., Aoki H., Sampath T.K., Enomoto S., et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblasts differentiation. Mol. Biol. Cell 1999, 10:3801-3813.
19. Hermeking H., Lengauer C., Polyak K., He T.C., Zhang L., Thiagaliangam S., Kinzler K.W., Vogelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1997, 1:3-11.
20. Samarakoon R., Overstreet J.M., Higgins P.J. TGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities. Cell Signal 2013, 25:264-268.
21. Ferguson A.T., Evron E., Umbricht C.B., Pandita T.K., Chan T.A., Hemeking H., et al. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc. Natl. Acad. Sci. USA 2000, 97:6049-6054.
22. Iwata N., Yamamoto H., Sasaki S., Itoh F., Suzuki H., Chikuchi T., et al. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene 2000, 19:5298-5302.
23. Yang H., Wen Y.Y., Zhao R., Lin Y.L., Fournier K., et al. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res. 2006, 66:3096-3105.